Geneva, Dec. 23 -- International Clinical Trials Registry received information related to the study (ACTRN12625001404415) titled 'Hypoxia Therapy for Recovery from Delayed Onset Muscle Soreness (DOMS)' on Dec. 15.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: Guillermo Garcia-Perez-de-Sevilla - Universidad Europea de Madrid
Condition:
Delayed Onset Muscle Soreness (DOMS)
Delayed Onset Muscle Soreness (DOMS)
Musculoskeletal - Other muscular and skeletal disorders
Intervention:
The intervention process will last for five days, with hypoxia administered from Day 1 following the delayed...